Greenwich LifeSciences
GLSI
34 hedge funds and large institutions have $17.6M invested in Greenwich LifeSciences in 2024 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 10 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 4
37% more capital invested
Capital invested by funds: $12.9M → $17.6M (+$4.77M)
30% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 10
10% more funds holding
Funds holding: 31 → 34 (+3)
2.91% more ownership
Funds ownership: 5.02% → 7.93% (+2.9%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$3.69M |
| 2 |
Credit Agricole
Montrouge Cedex,
France
|
+$1.27M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.01M |
| 4 |
State Street
Boston,
Massachusetts
|
+$809K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$658K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$1.27M |
| 2 |
Goldman Sachs
New York
|
-$828K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$715K |
| 4 |
Jane Street
New York
|
-$412K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$345K |
GLSI Hedge Fund Activity: Q2 2024 in Review
34 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q2 2024, worth a combined $17.6M — up 37% from $12.9M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new GLSI positions and 10 closed out — a net gain of 3 holders — while 12 added to existing stakes and 4 trimmed.
The largest buyer was BlackRock, adding an estimated $3.69M. The largest seller was Millennium Management, exiting entirely with an estimated $1.27M sold.
- 34 institutional investors held Greenwich LifeSciences (GLSI) as of Q2 2024, up from 31 in Q1 2024.
- Funds reported $17.6M of Greenwich LifeSciences stock for Q2 2024, up 37% quarter-over-quarter.
- 13 funds opened new Greenwich LifeSciences positions in Q2 2024 and 10 closed out, a net change of +3 holders.
- The largest Greenwich LifeSciences buyer in Q2 2024 was BlackRock, an estimated $3.69M added.
- The largest Greenwich LifeSciences seller in Q2 2024 was Millennium Management, an estimated $1.27M sold.
Based on aggregated 13F filings for Q2 2024.